Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2021 Mar 5;8:586875. doi: 10.3389/fmed.2021.586875

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2021 Levast, Benech, Gasc, Batailler, Senneville, Lustig, Pouderoux, Boutoille, Boucinha, Dauchy, Zeller, Maynard, Cazanave, Le Thi, Josse, Doré, Laurent and Ferry.

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

PMC Copyright notice

Impact of the use of fluoroquinolone (FQ) on gut microbiota composition. (A) Shannon index distribution (genus level) at the end of treatment and at follow-up (15 days after antibiotic withdrawal) according to exposition to FQ; Wilcoxon test for paired comparison and, Mann-Whitney test for inter-group comparisons. (B) Richness (genus level) at the end of treatment and at follow-up (15 days after antibiotic withdrawal) according to exposition to FQ; Wilcoxon test for paired comparison and, Mann-Whitney test for inter-group comparisons. Principal coordinate analysis of Bray–Curtis distance at three different times of sampling for (C) patients treated with FQ or (D) without FQ; permutational multivariate analysis of variance. B, baseline; EOT, end of treatment; FU, follow-up. *p < 0.05; **p < 0.01; ***p < 0.001.